Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Izrael, Tel Awiw
Ari Raphael
29 lat doświadczenia
akredytacje :
Akredytacje :
Lung cancer treatment cost in Israel is primarily determined by the surgical method and therapy type, with complex diagnostics of lung cancer ranging from $1,500 to $3,800. Key surgical interventions such as a lobectomy run from $23,200 to $23,200, while chemotherapy for lung cancer costs between $3,200 and $7,800. Total expenses depend on the hospital tier and technology used, offering 30–80% savings compared to the US. Top treatment centers are located in Tel Aviv, Jerusalem, and Haifa.
Typical Lung Cancer Treatment Costs in Israel
Bookimed Expert Insight: Patients seeking world-class surgical expertise should prioritize JCI-accredited centers like Sourasky Medical Center. Dr. Ofer Merimsky there leads a service treating 400,000 patients annually with a 90% oncology success rate. For those requiring advanced technology, Assuta Medical Center offers robotic-assisted surgery for complex cases. Sourasky provides specialized lung cancer packages starting around $4,200 including clinic transfers for international patients.
| Izrael | Turcja | Austria | |
| Terapia protonowa | od $48,000 | od $70,000 | od $80,000 |
| System da Vinci do chirurgii robotycznej | od $22,500 | od $9,500 | od $22,000 |
| Stereotaktyczna radiochirurgia | od $19,000 | od $4,500 | od $17,000 |
| Operacja raka płuc | od $27,500 | od $17,000 | od $42,000 |
| Lobektomia (usunięcie płata płuca) | od $23,171 | od $7,320 | od $30,000 |
Profesor Ofer Merimsky specjalizuje się w raku płuca. Opracował innowacyjne protokoły leczenia zarówno we wczesnym, jak i zaawansowanym stadium choroby.
Dr. Yuri Goldes is the Deputy Director of General Surgery at Sheba Medical Center. He pioneered some of Israel’s first robotic resections for stomach and pancreatic cancers. Forbes Israel named him among the nation’s best gastrointestinal surgeons. In 2019, he received the Best Doctor of the Year award from the Israeli Ministry of Health.
Dr Ari Raphael prowadzi przełomowe badania kliniczne nad rakiem płuca w Centrum Medycznym Sourasky, koncentrując się na profilowaniu genomowym i immunoterapii.
Dr Zalmanova specjalizuje się w radioterapii raka płuc w Centrum Medycznym Assuta.
Israeli oncologists use advanced genetic screening and biomarker analysis to determine treatment candidacy. Next-generation sequencing (NGS) identifies driver mutations like EGFR and ALK for targeted therapy. Immunotherapy eligibility depends primarily on PD-L1 expression levels and microsatellite instability (MSI) testing within JCI-accredited facilities.
Bookimed Expert Insight: Israeli oncology centres like Sheba and Sourasky serve over 400,000 patients annually, creating a massive data pool for precision medicine. Leading specialists like Dr Ofer Merimsky utilize this volume to refine treatment protocols. Their experience with over 900 procedures helps them identify which patients will benefit most from targeted drugs versus standard chemotherapy.
Patient Consensus: Patients in Israel note that comprehensive mutation testing often shifts treatment plans away from chemo. They find that confirming tissue quality early prevents the need for repeat biopsies during the diagnostic phase.
Israel offers advanced lung cancer care including immunotherapy, targeted therapy, and robotic surgery. Centres use molecular profiling to identify genetic mutations. This allows for precision medicines like osimertinib. High-tech radiation like CyberKnife and VMAT provides non-invasive options for complex or inoperable tumours.
Bookimed Expert Insight: Israeli oncology centres like Sheba and Sourasky serve over 1,800,000 patients annually. They often provide access to novel therapies through clinical trials before they are widely available. For instance, Dr Ofer Merimsky at Sourasky has overseen over 900 procedures. This volume ensures specialists handle even the most complex Stage IV cases with high proficiency.
Patient Consensus: Patients in Israel value the fast, integrated diagnostic work-up. They note that molecular profiling often unlocks new targeted therapy options that were not available in their home countries.
Patients can obtain a remote second opinion from Israeli specialists before travelling. Major centres use telehealth frameworks for international case reviews. Senior oncologists evaluate diagnostic files and scans via video platforms. This process confirms diagnoses and outlines advanced treatment roadmaps digitally.
Bookimed Expert Insight: Israeli oncology centres excel at molecular matching for lung cancer. Specialists like Dr Nir Peled and Dr Jair Bar focus on specific genetic mutations. An early remote review can confirm if advanced immunotherapies like Keytruda are suitable. This often prevents unnecessary travel for patients whose cases don't require surgical intervention.
Patient Consensus: Individuals note that remote reviews provide clarity on local treatment plans versus Israeli options. Many find that sending full pathology and genetic testing results ensures the most accurate remote assessment. Patients from Australia value comparing these expert Israeli insights with their local multi-disciplinary team recommendations.
Israel's leading lung cancer oncologists include Prof. Ofer Merimsky at Sourasky Medical Center, Prof. Jair Bar at Sheba Medical Center, and Prof. Nir Peled at Herzliya Medical Center. These specialists lead major thoracic units. They focus on personalised immunotherapy and advanced targeted treatments.
Bookimed Expert Insight: Israeli oncology centres like Sheba and Sourasky serve over 400,000 patients annually. They often combine treatments into single-visit protocols. This efficiency is why medical tourists rank Israel among the top 10 global destinations. These JCI-accredited facilities offer rare specialised services like celiac plexus radiosurgery and CAR-T immunotherapy.
Patient Consensus: Patients in Israel emphasise finding specialists who join multidisciplinary tumour boards. They note it is essential to complete biomarker testing like EGFR or PD-L1 before finishing any long-term treatment plan.
Patients should plan for a total stay of 3 to 14 days in Israel for diagnostics or surgery. Complex therapies like radiotherapy or chemotherapy cycles can extend this period to 8 weeks. Specialists use JCI-accredited facilities in Tel Aviv and Haifa to manage rapid diagnostic workups.
Bookimed Expert Insight: Israeli oncology centres like Sheba and Sourasky often compress multi-step diagnostics into 72 hours. While a diagnostic package may only require 5 hotel nights, patients should note that pathology record transfers can cause delays. Bringing original pathology slides from Australia or requesting digital genomic profiling interpretation in advance can shave 4 days off the initial stay.
Patient Consensus: Patients note that staging and specialist reviews take longer than expected, making flexible return flights essential. Experience at Sourasky showed that everything was organised in a timely manner, but individuals should always confirm when they are medically cleared for the long-haul flight back to Australia.
Cała treść medyczna na tej stronie została przygotowana przez autorów z wykształceniem medycznym specjalistycznym i zweryfikowana przez certyfikowanych lekarzy w odpowiedniej dziedzinie. Recenzja medyczna: Fahad Mawlood, Redaktor medyczny, Data Scientist.
Ostatnia aktualizacja: July, 2026.
Wszystkie dane są dostarczane w celach ogólnie informacyjnych i mogą nie odzwierciedlać indywidualnych wyników lub doświadczeń.